2-O-β-D-Glucopyranosyl-L-ascorbic acid
(Synonyms: 抗坏血酸葡糖苷; AA-2βG) 目录号 : GC35094An L-ascorbic acid derivative with antioxidant and radioprotective activities
Cas No.:129499-78-1
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
2-O-α-D-Glucopyranosyl-L-ascorbic acid (AA-2G) is a glucosylated derivative of L-ascorbic acid that has antioxidant and radioprotective activities.1,2,3 It scavenges 2,2-diphenyl-1-picrylhydrazyl radicals in a cell-free assay (EC50 = 61 μM in 60% ethanol).1 AA-2G (5 mM) inhibits γ-radiation-induced cell death in CHO-10B2 and radiosensitive xrs5 cells, as well as UVC- or broadband UVB-induced cell death in CHO-10B2 and UV-sensitive UV135 cells.2 It is hydrolyzed to ascorbic acid by α-glucosidase and increases serum levels of ascorbic acid in rats and guinea pigs when administered orally at doses of 19.2 and 96 mg/animal, respectively.3 AA-2G (19.2 mg/animal per day) reverses weight loss and inhibits subcutaneous hemorrhage in guinea pigs fed a vitamin C-deficient diet.
1.Fujinami, Y., Tai, A., and Yamamoto, I.Radical scavenging activity against 1,1-diphenyl-2-picrylhydrazyl of ascorbic acid 2-glucoside (AA-2G) and 6-acyl-AA-2GChem. Pharm. Bull. (Tokyo)49(5):642-644(2001) 2.Maeda, J., Allum, A.J., Mussallem, J.T., et al.Ascorbic acid 2-glucoside pretreatment protects cells from ionizing radiation, UVC, and short wavelength of UVBGenes (Basel)11(3)238(2020) 3.Yamamoto, I., Suga, S., Mitoh, Y., et al.Antiscorbutic activity of ?-ascorbic acid 2-glucoside and its availability as a vitamin C supplement in normal rats and guinea pigsJ. Pharmacobiodyn13(11)688-695(1990)
Cas No. | 129499-78-1 | SDF | |
别名 | 抗坏血酸葡糖苷; AA-2βG | ||
Canonical SMILES | OC([C@H](O1)[C@H](CO)O)=C(O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO)O2)O)O)O)C1=O | ||
分子式 | C12H18O11 | 分子量 | 338.26 |
溶解度 | DMSO: 1 mg/ml,PBS (pH 7.2): 1 mg/ml | 储存条件 | 4°C, protect from light |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.9563 mL | 14.7815 mL | 29.5631 mL |
5 mM | 0.5913 mL | 2.9563 mL | 5.9126 mL |
10 mM | 0.2956 mL | 1.4782 mL | 2.9563 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。